While GLP-1 receptor agonists have surged in popularity as miracle treatments for Type 2 diabetes and weight loss, a new report highlights a critical complication for a specific subset of patients ...

From the first notes of Christmas songs in September to the final Media Noche countdown in January, the Philippine holiday ...

With the year 2026 on the horizon, it is apparent that health organisations such as WHO, CDC, and AHA are making one thing ...

Most flu cases in Indonesia and worldwide are mild, but high-risk groups may need antiviral treatment if symptoms worsen, ...

Learn about the medical advancements and challenges faced by older adults living with HIV. Experts and survivors share their insights.

The new year could bring dramatic changes to health care. Michigan doctors highlight the top 5 things they expect to see in ...

Meanwhile, herd immunity among children is decreasing. In today’s issue: The Trump administration reduces the number of shots recommended for children. … The Justice Department defends Medicare’s drug ...

Doctronic reports that AI healthcare visits primarily involve managing chronic conditions like thyroid disorders, diabetes, and high cholesterol.

WASHINGTON (AP) — Flu is rising rapidly across the U.S., driven by a new variant of the virus — and cases are expected to ...

As colder temperatures settle across Victoria and surrounding Crossroads communities, healthcare providers are seeing a ...

Gestational diabetes has shifted from a niche clinical concern to a central storyline in American pregnancy care, with ...

Danish pharmaceutical giant Novo Nordisk announced Monday the US Food and Drug Administration (FDA) had approved its popular ...